Figure 5.
Effectiveness of chemotherapy strongly depends on the ability of ovarian cancer cells to undergo drug-induced apoptosis. Inactivation of p53 increase resistance to platinum-based chemotherapy by reducing the sensitivity of cells to activate apoptotic responses. The balance of proapoptotic and antiapoptotic proteins of the Bcl-2 family is a key factor to promote the sensitivity of platinum-based chemotherapy.